
Foods, Год журнала: 2025, Номер 14(9), С. 1531 - 1531
Опубликована: Апрель 27, 2025
Alzheimer’s disease (AD) has emerged as a global public health priority characterized by escalating prevalence and the limited efficacy of current therapeutic approaches. Although pathological complexity AD is well-recognized, its underlying etiology remains incompletely elucidated. Current research highlights bidirectional gut–brain axis (GBA) interaction, wherein gut microbiome perturbations may impair intestinal barrier stability, influence immune responses, blood–brain permeability through microbial metabolite-mediated pathways, thereby contributing to pathophysiology. Notably, probiotics demonstrate potential restoring homeostasis, reinforcing integrity, mitigating neuroinflammatory responses via GBA. This review focuses on investigating alterations in pathogenesis, interaction with GBA, significance pathogenesis. By synthesizing clinical evidence, this aims establish scientific foundation for probiotic-based interventions novel strategy management.
Язык: Английский